Hyperoside alleviates postmenopausal osteoporosis via regulating miR-19a-5p/IL-17A axis.
Sign Up to like & getrecommendations! Published in 2023 at "American journal of reproductive immunology"
DOI: 10.1111/aji.13709
Abstract: PROBLEM Postmenopausal osteoporosis (PMO) is a common osteoporosis. Hyperoside (Hyp), a natural flavonoid compound, has anti-osteoporotic effects, but the underlying mechanisms remain poorly understood. Inflammatory cytokine IL-17A is upregulated in PMO and plays vital roles… read more here.
Keywords: mir 19a; 19a 17a; pmo; 17a axis ... See more keywords